Venture Map · Round
Universal DX — Other · €14M
Announced 2021-01-14 · Sevilla · Biotech / Diagnostics
Seville biotech Universal DX develops blood tests for early cancer detection. It closed a €14M round, €4M more than planned, funded by existing shareholders, to finish clinical work on its colon cancer test. It had raised €35M in total by then.
RoundOther
Amount€14M
LeadNot disclosed
Date2021-01-14
CitySevilla
SectorBiotech / Diagnostics
The company
Investors
No investors were disclosed for this round.